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Elevated bone marrow adiposity (BMA) is defined as an increase in the proportion of 
the bone marrow (BM) cavity volume occupied by adipocytes. This can be caused 
by an increase in the size and/or number of adipocytes. BMA increases with age in a 
bone-site-specific manner. This increase may be linked to certain pathophysiological 
situations. Osteoporosis or compromised bone quality is frequently associated with high 
BMA. The involvement of BM adipocytes in bone loss may be due to commitment of 
mesenchymal stem cells to the adipogenic pathway rather than the osteogenic pathway. 
However, adipocytes may also act on their microenvironment by secreting factors with 
harmful effects for the bone health. Here, we review evidence that in a context of energy 
deficit (such as anorexia nervosa (AN) and restriction rodent models) bone alterations 
can occur in the absence of an increase in BMA. In severe cases, bone alterations 
are even associated with gelatinous BM transformation. The relationship between BMA 
and energy deficit and the potential regulators of this adiposity in this context are also 
discussed. On the basis of clinical studies and preliminary results on animal model, we 
propose that competition between differentiation into osteoblasts and differentiation into 
adipocytes might trigger bone loss at least in moderate-to-severe AN and in some calo-
rie restriction models. Finally, some of the main questions resulting from this hypothesis 
are discussed.
Keywords: bone marrow adiposity regulation, osteoporosis, gelatinous bone marrow transformation, mesenchymal 
stem cell differentiation, anorexia nervosa
iNtrODUctiON
The bone marrow (BM) is predominantly composed of two fractions, namely the hematopoietic and 
stromal fractions. Mesenchymal progenitor cells reside in the stromal fraction of the BM and can 
differentiate primarily into osteoblasts and adipocytes (1).
Bone marrow adiposity (BMA) is defined as the proportion of the BM cavity volume occupied 
by adipocytes. A rise in the BMA can be caused by an increase in the size and/or number of adipo-
cytes (2). BMA levels differ for males vs. females; they are usually higher in women than in men, 
and higher in female animal models than in males (3). It is also well known that BMA increases 
with age in a bone-site-specific manner. At birth, the BM is largely hematopoietic (red mar-
row) but is gradually converted to fatty (yellow) marrow over the lifespan (4–7). The age-related 
progression of BMA in the axial skeleton differs from that observed in the appendicular skeleton. 
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The fat fraction in iliac crest biopsies is relatively low during 
childhood but increases gradually with age (8). In  contrast, 
BMA in long bones of the limbs starts to rise during the first 
few years of life, with progressive colonization of the medullar 
cavity from the diaphysis. This process is complete at the age of 
25 years or so (9).
These observations suggest that (i) the presence of adipocytes in 
the BM is a physiological, age-related phenomenon, and (ii) these 
adipocytes may have positive effects. In fact, adipocytes can sup-
ply energy for the high level of bone remodeling required during 
puberty (10, 11). Furthermore, BM adipocytes may be involved 
in thermogenesis and heat dissipation because they display some 
of the characteristic features of brown adipocytes (12). However, 
an increase in BMA may be linked to certain pathophysiological 
situations. In fact, osteoporosis or compromised bone quality 
related to mechanical unloading (13), aging (14), menopause 
(15), diabetes (16, 17), obesity (18, 19), or anorexia nervosa (AN) 
(20) is frequently associated with high BMA [for a review, see the 
article by Hardouin et al. (21) in this special issue].
Two hypotheses have been proposed to explain the bone 
alterations induced by BMA increase: (i) the elevated BMA 
observed in osteoporotic patients is caused by a shift in mesen-
chymal stem cell commitment from the osteogenic pathway to 
the adipogenic pathway at the expense of bone formation (22–24) 
and (ii) BM adipocytes can regulate the BM microenvironment 
and act negatively on the balance between bone formation and 
bone resorption (11, 25–27) and hematopoiesis (28–31).
A better understanding of the quantitative and/or qualitative 
changes in BM adipocytes during osteoporosis might enable 
the development of novel therapeutic strategies. Of the various 
pathologic contexts associated with osteoporosis, AN is of par-
ticular interest. Although osteoporosis in AN has been extensively 
described, the present article discusses changes in BMA and the 
regulation of this process in a context of energy deficit and, then, 
proposes some perspectives for research in this specific field.
BMA AND eNerGY DeFicit
Anorexia nervosa is a major public health concern; it is the psy-
chiatric disease with the highest mortality rate. Given that AN 
often coincides with puberty, this condition markedly interferes 
with bone mass gain and has a long-term impact on bone qual-
ity (32). In particular, studying AN may reveal novel, hitherto 
unsuspected links between BMA and bone mass. First, secondary 
osteoporosis in AN is often associated with an increase in BMA 
that contrasts with a decrease in the adiposity of other fatty tissues 
(Table 1). Second, some studies (but not others) have found that 
levels of inflammation markers are not elevated in patients with 
AN (despite amenorrhea) (33, 34). Given that most patients with 
AN have a low bone mass, inflammation-independent mecha-
nisms may be involved in this bone loss.
However, the fact that a link between energy deficit and 
increased BMA is not always observed raises questions as to the 
relevance of BMA in AN. Indeed, several studies of osteoporo-
tic patients with AN did not observe elevated BMA (Table  1). 
In fact, the studies having found an increase in BMA tended to 
feature patients with a higher body mass index (BMI) than those 
in studies that did not observe this increase. Moreover, a number 
of studies that categorized patients into BMI classes highlighted a 
relationship between the severity of body weight loss and changes 
in the BMA (40, 43, 44). Interestingly, Abella et al.’s histological 
study of patient biopsies described a hypoplastic BM in which 
an increase in both the fat fraction and adipocyte diameter was 
associated with moderate body weight loss (40). The researchers 
also observed areas of unaffected or hypoplastic BM and focal 
gelatinous degeneration in patients with intermediate levels 
of body weight losses (40). Last, the most severe cases featured 
a high microadipocyte count in a hyaluronic acid matrix. It is 
noteworthy that, in one of the patients in Abella et al.’s study, the 
BM’s appearance normalized after the resumption of food intake 
and the return to an appropriate bodyweight (40). Vande Berg 
et al. used magnetic resonance imaging to highlight the presence 
of serous-like BM at different skeletal sites in anorectic patients 
(44). They distinguished between two groups as a function of the 
presence (group A) or absence (group B) of a water-like pattern 
in the marrow spaces. The individual BMI values in the group 
A were all under 13.5  kg/m2, whereas six of the eight patients 
in group B had a BMI above 15 kg/m2. Abella et al. did not find 
an intergroup difference in disease duration, which suggests that 
body weight loss is a key factor in BM alterations (39–41, 46).
This short overview of the relationship between BMA 
alterations and the severity of the body weight loss highlights 
the complexity of the processes leading to these alterations 
and probably, thereafter, to bone loss. Studies of animal models 
should provide some clues to these processes. In rodent models of 
food restriction or calorie restriction, only four published studies 
have focused on BMA (Table 2). First, Hamrick et al. studied the 
effects of a 40% food restriction in 14-week-old male mice (60). 
The 10-week protocol led to a body weight loss of 30% (relative 
to control mice) and the total disappearance of BM adipocytes in 
the distal femur and lumbar vertebra (60) (two adipocyte-poor 
medullar sites). Despite this lack of adipocytes, the cortical thick-
ness fell in the femur and lumbar vertebra, and the trabecular 
thickness fell in the femur (60). However, Devlin et al.’s 2010 study 
of the effects of a 9-week, 30% food restriction in 3-week-old male 
mice highlighted decreases of 11 and 27% in the bone volume/
total volume (BV/TV) ratio and in cortical thickness, respectively 
(61). Although this protocol induced a relative body weight 
loss of 40% (compared with control mice), the food-restricted 
animals were nevertheless 80% heavier at the end of the protocol 
than at the start. The main impact on bone microarchitecture was 
observed in the femur, where the BM adipocyte density was 700% 
higher than in control animals. Third, Baek and Bloomfield fed 
6-month-old Sprague-Dawley female rats a calorie-restricted diet 
for 12 weeks (62). At the end of this period, the calorie-restricted 
rats displayed body weight losses of 20% (relative to day 0) and 
25% (relative to control rats). The volumetric bone mineral 
density of the proximal tibia was 14% below that of control 
mice, while the BMA in the proximal femur had doubled. More 
recently, Cawthorn et al. showed that 6 weeks of a 30% calorie-
restricted diet in 9-week-old female mice induced a final increase 
in tibia BMA of 700% vs. mice able to feed ad libitum (27). In our 
separation-based model of AN (SBA), 8-week-old female mice 
were housed singly and submitted to time-restricted feeding (in 
tABle 1 | variations in BMA and the presence of gelatinous BM transformation in patients with AN, as reported in case–control studies and case reports.
N Age BMi BMA measurement site Method for 
measuring  
BMA
change  
in BMA
Presence 
of GBMt
Anorexic/
normal
Anorexic/normal Anorexic/normal
Bredella et al. (35) 14/12 29.5 ± 7.1/30.8 ± 6.6 17.7 ± 1/22.1 ± 1.7 Femoral diaphysis (1)H-MRS ↑ ND
Fazeli et al. (36) 7/15 33.1 ± 2.8 18.2 ± 0.6/21.9 ± 0.4 Lumbar vertebra (1)H-MRS ↑ ND
Proximal femoral epiphysis →
Proximal femoral metaphysis →
Proximal femoral diaphysis →
Ecklund et al. (37) 30/– 16.1 ± 1.6/16.3 ± 1.6 16.9 ± 1.5/22.3 ± 2.0 Distal femoral metaphysic MRI and 
relaxometry
↑ ND
Proximal tibia metaphysis ↑
Bredella et al. (20) 10/10 29.8 ± 7.6/30.8 ± 6.6 17.6 ± 1/21.9 ± 1.7 Lumbar vertebra (1)H-MRS ↑ ND
Proximal femoral epiphysis →
Proximal femoral metaphysis ↑
Proximal femoral diaphysis ↑
Mayo-Smith  
et al. (38)
15/58 15–33/18–44 ND/ND Lumbar spine (L1-L4) Dual energy CT 
scanning
↑ ND
Geiser et al. (39) 20/19 15–56/21–56 14.5/22 Femoral epiphysis (1)H-MRS and 
relaxometry
↓ ND
Femoral diaphysis →
Lumbar spine →
Abella et al. (40) 44/– 22.5 ± 5.3/– ND/– Iliac crest Histology ↑ in 35%  
of cases
In 50% of 
cases
Boutin et al. (41) 10/– 17–57/– ND/– Many different bone sites MRI ND In all cases
Lambert et al. (42) 10/19 17.2 ± 0.7/18.7 ± 0.5 14 ± 0.5/22.3 ± 0.4 Lumbar spine, pelvis, proximal 
femur
MRI ND 40% of 
cases
Vande Berg  
et al. (43)
19/– 15–35/– –/– Proximal to distal lower limb MRI ND 79% of 
cases
Vande Berg  
et al. (44)
14/– 27 ± 10/– 13.9 ± 2.6/– Lumbar spine, pelvis, proximal 
femur
MRI ND 43% of 
cases
Mant and 
Faragher (45)
6/– 16–44 ND Iliac crest Histology ND 83% of 
cases
Case reports of 
AN with GBMTa
18 12.1 ± 1.5/9.3–16 Iliac crest for half of the cases. 
Proximal femur, pelvis, foot or 
not specified for the other cases
Histology, 
cytologyb
↓ All cases
BMI, body mass index; BMA, bone marrow adiposity; GBMT, gelatinous bone marrow transformation; H-MRS, proton magnetic resonance spectroscopy; ND, not determined; MRI, 
magnetic resonance imaging; CT, computed tomography; ND, not determined; AN, anorexia nervosa.
Arrows: the variations in patients with AN differed significantly from those observed in control subjects.
aData from 15 case reports on GBMT in patients with AN (46–59).
bExcept for two cases where MRI was applied.
tABle 2 | variations in BM adipose tissue (BMAt) content in calorie-restricted rodent models.
characteristics 
of the model 
Period of protocol BW Bone BMAt content reference
Male mice 40%, 
food restriction
From 14 to  
24 weeks of age
−30% vs. ad libitum Low cortical and low trabecular thickness 
(femur)
−100% (distal femur) Hamrick et al. (60)
Male mice 30%,  
calorie restriction
From 3 to  
12 weeks of age
−40% vs. ad libitum
+80% vs. day 0
Low cortical thickness and low trabecular  
BV/TV (femur)
+700% (distal femur) Devlin et al. (61)
Female rats From 6 to  
9 months of age
−25% vs. ad libitum
−20% vs. day 0
Low trabecular volumetric bone mineral 
density but non-significant changes in 
cortical bone (tibia)
+100% (proximal  
femur)
Baek and 
Bloomfield (62)
Female mice, 30% 
calorie restriction
From 9 to  
15 weeks of age
−23% vs. ad libitum
−3% vs. day 0
Low trabecular thickness and low cortical 
volume (tibia)
+700% (tibia, above 
fibula junction)
Cawthorn et al. (27)
Female mice, time-
restricted feeding
From 8 to  
18 weeks of age
−40% vs. ad libitum
−25% vs. day 0
Low trabecular BV/TV and thickness, low 
cortical thickness (tibia)
Non-significant  
(proximal tibia)
Zgheib et al. (63) and 
unpublished data
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order to avoid a compensatory increase in food intake and, thus, 
attain a daily food intake close to that of ad libitum mice) (63). 
The calorie-restricted animals rapidly lost around 25% of their 
initial body weight, which corresponded to a body weight loss 
of 40% (relative to control mice) after 10 weeks of the protocol. 
The bone mass gain observed in control mice was curtailed after 
2 weeks of the protocol (63). After 10 weeks, the tibia trabecular 
BV/TV ratio, trabecular thickness, and cortical thickness were, 
respectively, 32, 31, and 15% lower in SBA mice than in control 
mice. However, the BMA level in the proximal tibia was similar 
to that observed in control mice (unpublished data). These results 
showed (as did Hamrick et  al.’s study) that energy deficit can 
4Ghali et al. Bone Marrow Adiposity and Energy Deficit
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induce bone alterations in the absence of an obvious increase in 
BMA (60). Interestingly, Cawthorn et  al. showed very recently 
that, in rabbit, CR leads to bone loss, even without increases in 
BMA (64).
To learn more from these animal datasets about BMA regula-
tion, one can attempt to compare them. The five above-mentioned 
studies assessed rodents of different genders and at different ages. 
The well-known differences between male and female physiology 
and the differences in BMA variation with age make it difficult to 
compare males with females (65). For the studies of male animals, 
the difference in observed BMA changes between Hamrick et al.’s 
study and Devlin et al.’s study might be linked to the age differ-
ence. One might conclude that calorie restriction induces a large 
increase in BMA in young male rodents only. However, it is also 
noteworthy that there is a late-onset BMA increase in male con-
trol mice; this might reduce the possible BMA increase in older 
animals (as observed at the end of Hamrick et al.’s study). When 
considering the three studies of female rodents, Baek’s work was 
performed on rats aged up to 9 months. It is difficult to compare 
old female rats with the 8- and 9-week-old C57Bl/6 female mice 
used by Cawthorn et al. and Zgheib et al., respectively. The main 
differences consisted in the body weight changes (relative to the 
start of the study) and the BMA changes in the tibia. Cawthorn 
et al. observed a stable body weight and a 700% increase in BMA, 
whereas Zgheib et al. observed a 25% decrease in body weight but 
no significant change in BMA. Given that these two models were 
similar enough to enable a valid comparison, one can hypothesize 
that the magnitude of body weight loss influences the change in 
BMA most strongly in young adult female mice.
POteNtiAl reGUlAtOrs OF BMA iN A 
cONteXt OF eNerGY DeFicit
As described above, it appears that BMA may be modulated by 
age, gender, and the severity of the energy deficit. However, it is 
important to bear in mind that BMA can also be affected by many 
different biological factors, including hormones, growth factors, 
and pharmacologic agents. Although the molecular mechanisms 
involved in BMA regulation have not been fully defined, they 
appear to converge on the modulation of peroxisome proliferator 
activated receptor gamma 2 (PPARγ2) expression and/or activity.
When considering potential regulators of BMA in subjects 
with a severely reduced calorie intake, it has been shown that 
dysregulation of the growth hormone insulin-like growth factor 
1 axis and low leptin levels can stimulate BM adipogenesis (19, 
61, 66). Moreover, starvation prompts the mobilization of fat 
stores, which might activate PPARγ2 and stimulate adipocyte 
differentiation in the BM (27). Furthermore, calorie restriction 
in a mouse model resulted in low expression and activity of runt-
related transcription factor 2 (Runx2) and tafazzin (TAZ), both 
of which are pro-osteogenic transcriptional factors in BM stromal 
cells (67, 68).
Several other investigators have established links between 
BMA and pre-adipocyte factor 1 (Pref1). Indeed, circulating 
Pref1 concentrations are higher in women with AN than in 
healthy controls (66). In women who have recovered from 
AN, Pref1 levels are significantly lower than in normal-weight 
controls (66). Hence, it is possible that elevated Pref1 levels in 
AN may be involved in the increase in BMA.
It is also known that the production of reactive oxygen spe-
cies (ROS) is greater in AN patients than in control subjects 
(69). ROS greatly influence the generation and survival of bone 
cells (70). In vitro studies of bone metabolism have shown that 
oxidative stress inhibits osteoblastic differentiation and induces 
apoptosis (71, 72).
Interestingly, women with AN have higher cortisol levels than 
healthy controls (73, 74). Cortisol levels are also predictive of a low 
bone mineral density in AN (73). In animal models, Cawthorn 
et al. showed that both BMA and glucocorticoids increase during 
CR in mice, but neither of these increases during CR in rabbits, 
suggesting a narrow link between these two phenomena (64). 
Experiments in vitro suggest that corticosteroids lead to adipo-
genesis by activating PPARγ2 and blocking the Wnt signaling 
pathway (75, 76). These findings also suggest that cortisol, Pref1, 
and leptin are all potential BMA regulators in a context of energy 
deficit.
Furthermore, women with AN have low estrogen levels (77, 
78). Postmenopausal estrogen deficit has been linked to high BMA 
(79). In vitro studies have demonstrated that estradiol induces a 
pro-osteogenic lineage shift in BM stromal cells, whereas estrogen 
deficit in aging mice was found to induce a decrease in the expres-
sion and activity of the pro-osteogenic, anti-adipogenic factor 
sirtuin type 1 (80, 81). One can, thus, conclude that estrogen is 
likely to be involved in the regulation of BMA.
Moreover, it is important to note that BM adipose tissue 
(BMAT) expansion contributes significantly to the elevated 
serum adiponectin levels and skeletal muscle adaptation observed 
during CR (27). Indeed, the study by Cawthorn et al. suggested 
that BMAT is a major source of circulating adiponectin in states 
of leanness, and that (through endocrine functions) BMAT can 
have extraskeletal, systemic effects (27). Thus, adiponectin may 
also regulate BMA in this context.
Last, it is probable that ongoing and/or future research will 
prompt us to take account of new factors that regulate adiposity 
in a context of energy deficit.
PersPectives
This short overview of the relationship between BMA alterations 
and the severity of body weight loss highlights the complexity 
of the underlying processes and the mechanism of subsequent 
bone loss.
With a view to designing BMA-focused therapeutic strategies 
against osteoporosis in a context of energy deficit, one major 
question is “do BM adipocytes trigger bone loss in a context of 
energy deficit?” Several studies of patients with AN have shown 
that average-to-severe body weight loss tends to lead to normal 
or decreased BMA. This suggests that (i) the BMA increase 
observed in patients with mild body weight loss may be a late 
marker of changes that occur in BM and that result in low bone 
mass, and (ii) the absence of an increase in BMA does not nec-
essarily mean that the skeleton is healthy. Some studies of CR 
animal models have shown that bone quality can decrease when 
the BMA is stable or even when it falls. This finding suggests 
5Ghali et al. Bone Marrow Adiposity and Energy Deficit
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that (at least in these models) hypotheses based on the effect 
of factors released by mature adipocytes on the BM microen-
vironment are not the most realistic. If the latter phenomenon 
is nevertheless involved, it might have a secondary role in the 
downregulation of bone physiology. Thus, BM adipocytes might 
not trigger bone loss in moderate-to-severe AN and in some CR 
models. Next, hypotheses involving competition between dif-
ferentiation into osteoblasts and differentiation into adipocytes 
should be considered. Interestingly, our analysis of the differen-
tiation capabilities of BM stromal cells from SBA and control 
mice found that the SBA cells displayed a huge increase in 
adipogenesis at the expense of osteoblastogenesis (unpublished 
data). This was observed in SBA mice that displayed normal or 
low BMA, which led us to suppose that the BM of these mice 
contains many pre-adipocytes that are not able to synthesize 
and store lipids in  vivo. These preliminary results strengthen 
the second hypothesis, although further experiments will be 
required to confirm these observations and to determine which 
factors in the culture medium trigger this pre-adipocyte matura-
tion and adipocyte activity. The glucose concentration appears 
to be a relevant candidate factor. However, favoring hypotheses 
based on the importance of pre-adipocytes raises another ques-
tion: “Do pre-adipocytes influence their microenvironment?” The 
characterization of stromal cells at the earliest stage in culture 
might help to answer this question.
If one acknowledges that a shift in the differentiation of 
BM stromal cells toward the adipocyte lineage is the main BM 
event during bone mass loss in a context of energy deficit, the 
next question would be “how is this commitment regulated?” 
One way of addressing this question would be to develop CR 
models with different levels of body weight loss. One could 
then compare BMA, bone quality/turnover, concentrations of 
circulating hormones known to have effects on adipogenesis 
and osteoblastogenesis, and the BM stromal cells’ differentia-
tion capabilities.
Tools are already available for studying how the differentiation 
of BM stromal cells is reprogrammed in animal models of CR 
and how differentiation is linked to the associated low bone mass. 
However, the development of novel tools for the in vivo assess-
ment of specific cell types in the BM (such as pre-adipocytes) 
remains a true challenge.
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